Common stock for Restore Medical Inc, St. Paul, Minn, is set to be traded on the NASDAQ stock market under the symbol “REST,” an appropriate mark seeing that the company manufactures and markets medical devices to treat sleep disorders.
Restore is best known for its Pillar® Palatal Implant, a Food and Drug Administration (FDA)-cleared implantable treatment for snoring and mild-to-moderate obstructive sleep apnea (OSA). The company has set the price for the initial public offering of 4,000,000 shares of common stock at $8.00 per share and has granted the underwriters an option to purchase up to an additional 600,000 shares of common stock at the initial public offering price to cover over-allotments, if any. A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission.
For more information about Restore Medical, the Pillar Procedure, and physicians who offer the Pillar Procedure in the US, visit the company’s Web site at www.restoremedical.com or www.pillarprocedure.com.